“Association Between Early Clinical Responses and Long-Term Outcomes With Ruxolitinib Cream Treatment in Mild to Moderate Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 8, no. 2 (March 18, 2024): s373. Accessed April 19, 2026. https://skin.dermsquared.com/skin/article/view/2607.